This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Centre Leon Berard, Centre National De La Recherche Scientifique, Institut National De La Sante Et De La Recherche Medicale. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 39 
1 out of 132 
1 out of 12 Years Active: 2026
Title: Innovations in Cancer Prognosis by Jean-Philippe Foy
Introduction
Jean-Philippe Foy is a notable inventor based in Paris, France. He has made significant contributions to the field of cancer research, particularly in the area of prognosis methods. His innovative approach aims to improve patient outcomes and treatment resistance assessments for individuals afflicted by tumors.
Latest Patents
Jean-Philippe Foy holds a patent for a prognosis method of cancer. This method involves determining the expression levels of at least 21 genes from a group of 160 specific genes. The patent outlines a technique that helps predict patient outcomes and their resistance to chemotherapy treatments.
Career Highlights
Throughout his career, Jean-Philippe Foy has worked with esteemed institutions such as the Centre National de la Recherche Scientifique and the Centre Léon Bérard. His work in these organizations has allowed him to collaborate with leading experts in cancer research and contribute to advancements in medical science.
Collaborations
Some of his notable coworkers include Véronique Maguer-Satta and Boris Guyot. Their collaborative efforts have furthered research in cancer prognosis and treatment strategies.
Conclusion
Jean-Philippe Foy's innovative work in cancer prognosis exemplifies the impact of research and invention in improving healthcare outcomes. His contributions are vital in the ongoing fight against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile